Sat08302014

Last update 08:51:54 AM EST

Pfizer and Merck Partner to Test Cancer Immunotherapy Combo

Pfizer and Merck Partner to Test Cancer Immunotherapy Combo

Pfizer Inc. and Merck & Co. Inc. recently ...

Janssen Affiliate Cilag Acquires Covagen

Janssen Affiliate Cilag Acquires Covagen

Today, Cilag GmbH International, an affiliate ...

FDA Approves ViiV's HIV Pill

FDA Approves ViiV's HIV Pill

ViiV Healthcare recently announced that the US...

Baxter's Long-Acting Hemophilia Drug Demonstrates Positive Late-Stage Results

Baxter's Long-Acting Hemophilia Drug Demonstrates Positive Late-Stage Results

Baxter International Inc. recently announced that its investigational long-a...

FDA Lifts Partial Clinical Hold on OncoMed's Cancer Trials

FDA Lifts Partial Clinical Hold on OncoMed's Cancer Trials

OncoMed Pharmaceuticals, Inc. recently announced that the US Food and Drug A...

Kite Pharma's Non-Hodgkin Lymphoma Drug Demonstrates Positive Results in Early-Stage Study

Kite Pharma's Non-Hodgkin Lymphoma Drug Demonstrates Positive Results in Early-Stage Study

California-based Kite Pharma, Inc. recently announced positive results from ...

Pfizer and Merck Partner to Test Cancer Immunotherapy Combo

Pfizer and Merck Partner to Test Cancer Immunotherapy Combo

Pfizer Inc. and Merck & Co. Inc. recently announced that the companies w...

FDA Grants Orphan Drug Designation to Insys' Investigational Brain Tumor Drug

FDA Grants Orphan Drug Designation to Insys' Investigational Brain Tumor Drug

Today, Insys Therapeutics, Inc. announced that the US Food and Drug Administ...

Advaxis and Merck Collaborate to Test Prostate Cancer Combo Therapy

Advaxis and Merck Collaborate to Test Prostate Cancer Combo Therapy

Today, Advaxis, Inc. announced that it has entered into a clinical trial colla...

Study Finds Hera Therapeutics' Experimental Drug Stops Common HPV Cells

Study Finds Hera Therapeutics' Experimental Drug Stops Common HPV Cells

Hera Therapeutics Inc. has identified a therapy that appears to combat three...

Patheon Gets US Biologics Plants through Acquisition of Gallus BioPharmaceuticals

Patheon Gets US Biologics Plants through Acquisition of Gallus BioPharmaceuticals

DPx Holdings B.V. announced that it has entered into a definitive agreement ...

Axium Announced as Platinum Sponsor for NASP / SPAARx Annual Meeting & Expo

Axium Announced as Platinum Sponsor for NASP / SPAARx Annual Meeting & Expo

TAMPA, FL, August 26, 2014 - The National Association of Specialty Ph...

Janssen Affiliate Cilag Acquires Covagen

Janssen Affiliate Cilag Acquires Covagen

Today, Cilag GmbH International, an affiliate of the Janssen Pharmaceutical ...

FDA Approves ViiV's HIV Pill

FDA Approves ViiV's HIV Pill

ViiV Healthcare recently announced that the US Food and Drug Administration ...

FDA Expands Approval of GSK's Promacta for Treatment of Severe Aplastic Anemia

FDA Expands Approval of GSK's Promacta for Treatment of Severe Aplastic Anemia

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s (GS...

Roche to Acquire InterMune Expanding its Respiratory Portfolio

Roche to Acquire InterMune Expanding its Respiratory Portfolio

Swiss drugmaker Roche announced on Sunday that it has agreed to acquire US b...

Pfizer's Investigational Vaccine Receives Fast Track Designation from the FDA

Pfizer's Investigational Vaccine Receives Fast Track Designation from the FDA

Pfizer Inc. announced that the US Food and Drug Administration (FDA) granted...

Researchers Cure Rheumatoid Arthritis in Mice

Researchers Cure Rheumatoid Arthritis in Mice

European researchers have managed to cure arthritis in mice for the first ti...

Novel Biomarker Effective for Detection of Early Rheumatoid Arthritis

Novel Biomarker Effective for Detection of Early Rheumatoid Arthritis

According to a recent study, a novel biomarker for rheumatoid arthritis (RA)...